Integrated Multiparametric High-Content Profiling of Endothelial Cells by Wiseman, Erika et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1177/2472555218820848
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Wiseman, E., Zamuner, A., Tang, Z., Rogers, J., Munir, S., Di Silvio, L., ... Veschini, L. (2019). Integrated
Multiparametric High-Content Profiling of Endothelial Cells. SLAS discovery, 24(3), 264-273.
https://doi.org/10.1177/2472555218820848
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 10. Jul. 2020
https://doi.org/10.1177/2472555218820848
SLAS Discovery
2019, Vol. 24(3) 264 –273
© 2019 Society for Laboratory
Automation and Screening
DOI: 10.1177/2472555218820848
slasdisc.sagepub.com
Original Research
Introduction
Endothelial cells (ECs) form the inner lining of all blood 
and lymphatic vessels and are key mediators of functions 
such as vascular permeability, leukocyte trafficking, and 
angiogenesis (the formation of new blood vessels out of 
preexisting ones). Stable properties of specialized vessel 
types emerge from the collective behavior of neighboring 
heterogeneous ECs. Moreover, specific vasculature in tis-
sues is often composed of functionally heterogeneous ves-
sels (such as arteries, veins, lymphatics, and sinusoids). 
This diversity of function and complexity of scale (at the 
cell, vessel, and tissue level) are reflected in a remarkable 
degree of phenotypic heterogeneity. In essence, each of our 
~6.2 × 1011 ECs (on average, in humans, ~22% of all nucle-
ated cells and ~3% of all cells1–3) can be considered pheno-
typically distinct from all others (Fig. 1A).4
Experimentally, in vitro, this cell heterogeneity presents 
challenges for phenotypic characterization. Importantly, 
transformative changes are taking place in cell-based assays 
aimed at accurately profiling cells. For example, (1) com-
plex cultures (3D, bioprinting, organ-on-a-chip) are sur-
passing more traditional 2D cultures; (2) unbiased analysis 
of morphological parameters in endpoint and/or dynamic 
imaging in live assays is complementing antibody-based 
cell markers; and (3) primary or induced pluripotent stem 
cell (iPSC)-derived cell lines capturing the genetic back-
grounds of single individuals are becoming available. These 
shifts bring new exciting opportunities for translational 
research. Nonetheless, it is less often highlighted that these 
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Abstract
Endothelial cells (ECs) are widely heterogeneous at the cell level and serve different functions at the vessel and tissue levels. 
EC-forming colonies derived from induced pluripotent stem cells (iPSC-ECFCs) alongside models such as primary human 
umbilical vein ECs (HUVECs) are slowly becoming available for research with future applications in cell therapies, disease 
modeling, and drug discovery. We and others previously described high-content analysis approaches capturing unbiased 
morphology-based measurements coupled with immunofluorescence and used these for multidimensional reduction and 
population analysis. Here, we report a tailored workflow to characterize ECs. We acquire images at high resolution with 
high-magnification water-immersion objectives with Hoechst, vascular endothelial cadherin (VEC), and activated NOTCH 
staining. We hypothesize that via these key markers alone we would be able to distinguish and assess different EC 
populations. We used cell population software analysis to phenotype HUVECs and iPSC-ECFCs in the absence or presence 
of vascular endothelial growth factor (VEGF). To our knowledge, this study presents the first parallel quantitative high-
content multiparametric profiling of EC models. Importantly, it highlights a simple strategy to benchmark ECs in different 
conditions and develop new approaches for biological research and translational applications for regenerative medicine.
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Figure 1. EC characterization using high-content analysis. (A) Schematic representation of the origin of the examined cell types for 
this study. HUVECs are primary cells derived from the umbilical cord that are venous ECs. The range of ECs that can be derived from 
iPSCs is wider and less defined. (B) Microphotographs comparing HUVECs and iPSC-ECFCs untreated and upon exposure to VEGF; 
tile from nine microscopic fields, one of which is highlighted in the dotted white square in the top left. (C) At higher magnification, 
panels i and ii refer to HUVECs untreated or treated with VEGF, respectively, and panels iii and iiii refer to iPSC-ECFCs untreated or 
treated with VEGF, respectively. Red arrows highlight discontinuation in junctions. (D) Schematic of workflow for image acquisition, 
quantification, and analysis (further details are available in the Supplemental Material) describing in particular the modules for cell 
morphology, junctions, and NOTCH, with sample images of the segmented objects.
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changes also present substantial challenges in the acquisi-
tion and analysis of data, requiring innovative workflows 
and new approaches to integration. Importantly, novel ver-
sus traditional cell systems are rarely compared quantita-
tively and side by side.
We have recently described novel analysis tools to 
“benchmark” cells accounting for interexperimental varia-
tion5,6 with a view of future applications to include dynamic 
imaging.7 Moving forward substantially from previous 
work around neural stem cells,8 these approaches were 
developed for iPSCs and other cell types9 and offer unprec-
edented possibilities to combine experiments from different 
conditions into single coherent datasets.
Monolayer sheets of ECs are widely employed as a 
model for stable endothelia. Cell phenotype is commonly 
evaluated via observation of immunofluorescence 
images.10,11 Human umbilical vein ECs (HUVECs) are the 
most diffuse model. Remarkably, to our knowledge, no 
unbiased morphology approach to compare iPSC-derived 
EC types with HUVECs has been described to date. In the 
context of tissue development and growth, ECs play a fun-
damental role in chaperoning/directing the formation of tis-
sue functional units.12 Thus, obtaining tissue-specific 
iPSC-derived ECs (iPSC-ECs) to be used in microtissue 
engineering is an appealing goal. These models offer sig-
nificant potential for precision medicine and may provide a 
route to autologous cell therapy. Currently, available proto-
cols for iPSC-ECs mirror some of the heterogeneity found 
in vivo.13 Yet, stepwise procedures typically require the 
addition of specific growth factors at defined time points for 
more than 10 days. Cells are usually characterized via the 
expression of lineage markers at defined time points where 
intermediate populations are not analyzed extensively. 
Therefore, achieving “deep” characterization of iPSC-EC 
phenotypes individually, collectively, and temporally will 
lead to an improved understanding of the biology and defi-
nition of protocols with profound implications for research 
and translation.
High-content image analysis provides phenotypic infor-
mation at the subcellular, single-cell, and population levels. 
For example, the abundance and spatial distribution of vas-
cular endothelial cadherin (VEC) throughout the EC mem-
brane offers key information regarding cell activation 
status, including propensity to migrate or form a stable qui-
escent monolayer.14 NOTCH signaling is a key driver of EC 
specialization and a regulator of interendothelial adhesive-
ness and EC junctional stability.15 Thus, combining the 
study of VEC distribution and NOTCH activation at the cell 
level in association with morphological parameters and 
context features can result in a wealth of information regard-
ing EC regulatory status under specific conditions.
Here, we report a high-content EC phenotyping plat-
form using morphology, VEC staining, and analysis of 
NOTCH activation. Cell spreading and elongation (in 
“migratory” phenotypes) are key features to dissect 
diverse stages of differentiation. We therefore defined a 
method to assess these in an unbiased manner with a high-
content approach. We introduce morphology parameters 
(e.g., cell and nuclei area, roundness, width/length ratio 
together with an array of Symmetry, Threshold compact-
ness, Axial or Radial [STAR] features; see Supplemental 
Material for a complete list). Importantly, subcellular 
analysis of features (with analysis of junctions), popula-
tion stratification (via the NOTCH status), and context 
features (quantification of size for clusters of NOTCH-
positive cells) are collated. As the HUVEC response to 
vascular endothelial growth factor (VEGF) is very well 
characterized,10,14 we used this cell system as a reference. 
Subsequently, we employed our validated pipeline to 
investigate the phenotype of unstimulated or VEGF-
activated iPSC-EC-forming colonies (iPSC-ECFCs).16 
Based on their derivation protocols,16 these cells can be 
considered fully committed endothelial progenitors rather 
than definitive, mature, fully specialized ECs.
Altogether, the workflow described here serves as a 
roadmap toward phenotyping of ECs from different sources. 
This will help in characterizing phenotypes of ECs under 
different experimental conditions. Methods like the one 
described will hereby support the development and quality 
control of protocols for iPSC differentiation toward special-
ized (arterial, venous, lymphatic) or tissue-specific (renal 
glomerulus, liver sinusoid, etc.) cells for translational appli-
cations. Furthermore, characterization of diverse EC popu-
lations would open new routes to target pharmacologically 
specific EC subpopulations in precision medicine.
Materials and Methods
Cell Culture Reagents
HUVECs and iPSC-ECFCs16 (PromoCell, Heidelberg, 
Germany and Axol Bioscience, Cambridge, UK, respec-
tively) were plated on 10 µg/mL fibronectin (from human 
plasma, Promocell)-coated flasks, grown in EGM 2 medium 
(Promocell) in the absence of antibiotics, detached with 
Accutase (Thermo Fisher Scientific, Waltham, MA), and 
used by passage 3. For experiments, 5 × 104 ECs were 
seeded in the center of 22 × 22 mm fibronectin-coated cov-
erslips housed within a six-well plate well and cultured for 
48 h under basal (EGM 1, Promocell) or activated (EGM 1 
+ 50 ng/mL VEGFA, Peprotech, London, UK) conditions 
in duplicate. EGM 1 medium containing 1 ng/mL basic 
fibroblast growth factor (bFGF), 100 pg/mL EGF, and no 
VEGF was chosen in order to maintain the cells in quies-
cent conditions. The ECs formed confluent monolayers at 
the center of the slide where images were acquired.
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Immunostaining
Slides were fixed with 2% para-formaldehyde in phosphate-
buffered saline (PBS) for 10 minutes and then washed exten-
sively with PBS supplemented with 1% fetal bovine serum 
(FBS) and incubated (45 minutes) with Alexa 594-conju-
gated antibody against VEC (1:200, 1 µg/mL, BioLegend, 
San Diego, CA). VEC is a lineage marker for ECs and cells 
were all VEC+ (see Fig. 1B). After permeabilization (1 
minutes) in 0.1% Triton X-100, cells were incubated (45 
minutes) with primary anti-activated NOTCH antibody 
(Abcam 1:200, 1 µg/mL final). Subsequently, plates were 
washed and incubated with 1 µg/m: secondary Alexa 
488-conjugated antibody (30 minutes, Thermo). Nuclei 
were stained with Hoechst 33342 (1 µg/mL, 10 minutes, 
Sigma) and slides were mounted with Mowiol (Sigma).
Image Acquisition and Analysis
We obtained images from slides with an Operetta CLS sys-
tem (PerkinElmer, Waltham, MA) equipped with a 40× 
water-immersion lens (Numerical Aperture 1.1). On each 
slide, five areas were acquired. Each area is composed of 
nine microscopic fields at 40× magnification tiled with 
0.05% overlapping (Fig. 1B). For EC characterization, we 
designed the modular pipeline (represented schematically 
in Figure 1C and detailed in Supplemental Figures). We 
collected a total of 47 features derived from the modules 
described in the Supplemental Material. Briefly, we first 
identified nuclei with Hoechst and cytoplasm using the VEC 
marker (Ch A555, orange) for each cell and measured 
parameters including cell/nuclei area, length, and roundness. 
We subsequently identified the junctional area as peaks of 
VEC stain and assigned each object to its respective cell. We 
defined “junctions” as regions in the image that give a strong 
signal in the VEC marker and generate “edges” (according 
to the SER edge algorithm in the pipeline; see Supplemental 
Material). We calculated the average number of VEC-
positive objects per nuclei (Jn). This novel method was 
inspired by a previously reported study classifying EC junc-
tions based on VEC staining.15 In our method, high Jn cor-
responds to “active” junctions while low Jn refers to 
“inhibited” or “stable” junctions, which have been shown to 
correlate consistently with NOTCH signaling. Finally, we 
identified activated NOTCH as bright cytoplasmic or nuclear 
spots. We assigned each cell to N–/– (cell without spots, not 
active), N+/– (cell with spots in the cytoplasm only, not tran-
scriptionally active), or N+/+ (cell with spots in cytoplasm 
and nucleus or nucleus alone, putatively active). No signifi-
cant number of cells were identified with spots in the nucleus 
only, and therefore these were grouped in the N++ category. 
We divided cells in these groups based on current knowl-
edge regarding NOTCH protein compartmentalization dur-
ing NOTCH pathway activation.17 The antibody used in our 
assay reveals “activated NOTCH,” which corresponds to 
cleaved NOTCH intracellular domain (NICD). As a context 
feature, we evaluated the number of N+/+ cells in contact 
with each other (NOTCH clusters; see Fig. 1 and 
Supplemental Material); the clustering method was adapted 
from previous work in our laboratory.6,18 We ran the pipe-
line described using Columbus software (PerkinElmer) on a 
virtual machine in batch. Images for each experimental con-
dition in duplicate (40 images composed of nine tiles at 
40× OM in total) were analyzed and numerical data 
exported. .txt files were directly imported into Spotfire 
(Tibco Software, Palo Alto, CA) through the Columbus data 
repository link.
Data Integration and Analysis
Data were tagged prior to running High Content Profiler 
(HCP) in Spotfire (Tibco): cell type (HUVEC vs iPSC-EC), 
treatment (untreated vs VEGF). HCP was launched with the 
following settings: Other screen—plate well based—well 
analysis results—select all features (excluding metadata)—
select relevant annotations—run HCP. Different data explo-
ration tabs were generated. Features overview was used to 
capture feature values across plates (e.g., mean percentage 
of cells in the NOTCH categories) using raw data. We used 
hierarchical cluster analysis to identify clusters in an unsu-
pervised fashion. Column data were classified by cell type 
and treatment, and distances between features were mea-
sured according to Euclidean distance, normalized by mean 
and weight ordered by average value. For exploration of 
data structure, a principal component analysis (PCA)-
generated distribution was visualized with cell type + treat-
ment. Statistical analysis of relevant parameters was 
performed with GraphPad Prism. We performed one- and 
two-way ANOVA (as appropriate) followed by post hoc test 
for multiple comparisons to assess statistical significance.
Results
HUVECs in the Absence or Presence of VEGF 
Reveal Changes in Phenotypic Features
Confluent EC monolayers are widely used to model the 
endothelial barrier.19,20 In order to test our imaging workflow 
strategy and validate our approach, we first set out to evalu-
ate HUVECs, a well-established EC model.10,19 HUVECs 
under basal (quiescent) conditions demonstrate a polygonal 
shape with tight and continuous interendothelial junctions. 
Staining HUVECs with Hoechst and VEC highlighted clas-
sic cobblestone-like morphology (Fig. 1B). Under these 
conditions, ECs appeared small and in contact with each 
other, forming a continuous barrier. As expected,21 upon 
VEGF treatment, cells changed in shape, becoming stretched 
and elongated (Fig. 1B). We therefore hypothesized that 
268 SLAS Discovery 24(3) 
Figure 2. Selected features: morphology, junctions, NOTCH. HUVECs and iPSC-ECFCs in the absence and presence of VEGF 
are analyzed for cell morphology features such as roundness (A) and width-to-length ratio (B). Differences between cell types are 
apparent, and the cell width-to-length ratio is significantly changed in response to VEGF, whereas the nuclear width-to-length ratio 
(C) is not. (D) Quantification of Jn shows differences between the cell types. (E) NOTCH activation pattern for each experimental 
condition reveals a response of iPSC-ECFCs to VEGF. Statistical analysis, with ANOVA p values as follows: *p < 0.05, **p < 0.01, 
***p < 0.001.
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VEGF treatment would elicit in HUVECs changes in mor-
phology features that could be quantified by our image anal-
ysis pipeline. The ratio between cell width and length varied 
significantly, as cells were more stretched upon VEGF acti-
vation (Fig. 2B). Cell roundness, nuclei roundness, and 
nuclei width-to-length ratio (Fig. 2A,C,D) were not signifi-
cantly affected by the presence of VEGF. This change was 
consistent with a stretched “activated” cell morphology.
In microscopic images, we observed that VEC-stained 
junctions appeared discontinuous, interdigitated, and jag-
ged (Fig. 1B). In our pipeline, we identified discrete VEC-
stained regions surrounding each cell. We refined a 
parameter (Jn; see Materials and Methods and Supplemental 
Material) measuring the number of junctional objects per 
cell. We reasoned that Jn could be used as a proxy for the 
continuity of junctions and may increase in cells with jag-
ged junctions, as these present areas where the signal is 
much weaker (Fig. 1C, arrowhead). No significant differ-
ence for Jn was reported in HUVECs cultured in the absence 
or presence of VEGF (Fig. 2D).
Activated-NOTCH dots were visible in microscopic 
images (Fig. 1B; see Supplemental Material). Nonetheless, 
via simple observation, no clear-cut obvious difference in 
activated-NOTCH stain could be observed upon VEGF 
treatment as patterns appeared virtually undistinguishable 
from untreated conditions and differences were difficult to 
quantify (Fig. 1B). We then set out to quantify NOTCH 
activation using our automated pipeline. HUVECs had a 
high baseline NOTCH activity (>20% and >60% in the 
N+/– and N+/+ categories, respectively) and VEGF treat-
ment did not affect this distribution (Fig. 2E). The size of 
NOTCH-positive cell clusters presented a slight, not sig-
nificant, increase upon VEGF treatment (Fig. 2F).
Overall, our observation and measurements are consis-
tent with an “activation” effect of VEGF to the endothelium 
in HUVECs as seen by changes in the width/length ratio. 
Nevertheless, no major change was observed in Jn and 
NOTCH in HUVECs upon VEGF treatment, consistent 
with the possibility of some level of basal activation.
iPSC-EC Reveal a Distinct Phenotype to 
HUVECs, Confirmed by Unsupervised Clustering
HUVEC is a widely used and well-established model that 
arguably presents several limitations.20 ECs derived from 
iPSCs (iPSC-ECs) are considered more relevant models to 
study ECs. For example, it is possible to obtain a wider 
range of specialized cell types other than large-vein ECs. 
We therefore set out to observe HUVECs and iPSC-ECFCs 
in the absence or presence of VEGF.
Microscopic images (Fig. 1B) showed that untreated 
iPSC-ECFCs appeared distinct from HUVECs. The quanti-
fication of morphological features (Fig. 2A–D) showed a 
higher variance of the measured parameters, indicating a 
more phenotypically diverse cell population. In some cases, 
iPSC-ECFCs were more similar to VEGF-treated HUVECs 
(cell width/length ratio, Fig. 2B). Junctions appeared very 
different in microscopic images (Fig. 1B), and Jn was sig-
nificantly higher in iPSC-ECFCs (Fig. 2D) and responsive 
to VEGF. These results were consistent with looser intercel-
lular junctions in iPSC-ECFCs.
We later set out to quantify the response of iPSC-ECFCs 
to VEGF in terms of NOTCH activation. Untreated iPSC-
ECFCs were significantly more abundant in the N+/– and 
less abundant in the N+/+ category compared with HUVEC 
(Fig. 2E). Importantly, whereas VEGF had no observable 
effect on HUVECs, VEGF induced a significant increase in 
the N+/+ category and a decrease in the N+/– category in 
iPSC-ECFCs. Altogether, these results validated the 
selected feature changes observed in microscopic images, 
suggesting that iPSC-ECFCs present a more activated phe-
notype than HUVECs and a differential response to VEGF.
We hypothesized that cell types (HUVECs vs iPSC-
ECFCs) would be diverse enough and the phenotypic fea-
tures acquired would be sufficient to distinguish these cell 
populations. In other words, in our experimental conditions 
we could run unsupervised clustering, capturing, in an unbi-
ased manner, object populations reflective of diverse cell 
behavior. To test our hypothesis, we performed multidimen-
sional reduction and visualization. PCA for the three princi-
pal components reported an explained variance of more 
than 80%. The variance explained with principal compo-
nent 1 was 54% and rose to 74% with component 2 and 
81% with component 3 (Supplemental Material).
We observed the loading of 47 features (see Supplemental 
Material), including all of those described above into the 
first three principal components (Fig. 3A). All four NOTCH 
cluster parameters (Fig. 3A, red dots) loaded in a very simi-
lar way to the PCA, as expected. Also expectedly, the N+/+ 
category percentage value loaded in a neighboring way 
(Fig. 3A, highlighted). Other STAR and morphological fea-
tures were surrounding this group of NOTCH-related fea-
tures, suggesting that these could be predictive of NOTCH 
status in this setting.
In hierarchical clustering, different populations formed 
discrete clusters demonstrating that our analysis can sepa-
rate cell types (Fig. 3B). This was apparent in a PCA plot 
(Fig. 3C). Altogether, these results provide a defined set of 
parameters to clearly distinguish different EC populations.
Discussion
Previous studies have highlighted the feasibility of using in 
vitro high-content analysis with ECs to model aspects of 
angiogenic signaling and microvessel formation. Tubular 
network formation was evaluated in the HUVEC/fibroblast 
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Figure 3. Multidimensional reduction. (A) The obtained 47 features analyzed are projected in terms of their loadings on the three 
principal components. Note that four features referring to the NOTCH cluster size (in red) neighbor the N+/+ NOTCH activation 
category percentage. (B) Hierarchical clustering of the four conditions. (C) PCA reveals separation for HUVECs in the absence or 
presence of VEGF in a distinct cluster to iPSC-ECFCs.
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(HDF) co-culture assay.23 In other cases, multiparametric 
phenotypic profiles generated from a bespoke informatics 
platform were applied to screen compounds. High-
throughput assays focused on vascular assembly incorpo-
rated image-derived information from HUVEC nuclei.23,24
Moreover, comparisons between different EC types (pri-
mary and iPSC derived) have recently been reported with 
image analysis with respect to sprouting angiogenesis. The 
authors pointed to an impaired angiogenic potential of 
iPSC-ECFCs, possibly due to a less mature phenotype.25
Finally, the importance of VEC and NOTCH signaling 
cross-talks has been stressed.15,26,27 Altogether, these con-
siderations prompted us to quantify phenotypic features and 
use multiparametric high-content analysis with the precise 
goal of profiling distinct cellular phenotypes.
In this study, we offer a guide toward unbiased charac-
terization of ECs using multidimensional reduction of mul-
tiparametric high-content analysis data. We have sought to 
design a framework for EC phenotyping to evaluate cell 
morphology and two markers (VEC and active NOTCH) 
indicative of EC activation. Qualitative observation sug-
gested that iPSC-ECs used in this study were morphologi-
cally different from HUVECs, suggesting a differential 
activation status at baseline. Dissection of the molecular 
determinants of these EC phenotypes is beyond the scope of 
the present work.
Since HUVECs responded to VEGF in shape and not in 
Jn and NOTCH readouts, these parameters were useful to 
elicit differences between the cell types. We here describe a 
workflow to analyze distinct EC models in different condi-
tions. The high-resolution images we obtained are compa-
rable in quality and magnification to those from studies 
aimed at characterizing ECs that do not refer to high-con-
tent-based methods for analysis.10 We stained nuclei and 
evaluated phenotypic features from objects, cell–cell inter-
actions (junctions), and subcellular NOTCH staining 
(including context features).
HUVECs are an established cellular model for the study 
of vascular biology and angiogenesis. They have been the 
key to several findings.22 HUVECs are nonetheless a cell 
type derived from a specific body location (umbilical cord) 
and should be considered an effective model of ECs speci-
fied toward large-vein fate.11 Qualitative evaluation con-
firmed previous published observations where VEGF 
treatment induced prototypical morphological changes in 
HUVECs. It is interesting to observe, though, that the dif-
ferences appear significant for ratio width/length but not for 
roundness, suggesting a more “stellate” cell shape, which 
has been proposed to be associated with an activated migra-
tory environment-probing28 phenotype. It is also interesting 
that the nuclear width/length (Fig. 2C) does not appear to 
be a good proxy for this phenotype. Many mechanisms of 
EC biology have been investigated in HUVECs, and thus 
understanding the extent to which it is possible to compare 
novel cell types such as iPSC-ECFCs side by side is of sig-
nificant importance.
New possibilities are arising thanks to the development 
of iPSC technology. IPSC-ECs can be derived following 
protocols developed in recent years, and these protocols 
could enable us to produce specific cell types resembling 
the ample range of ECs found in vivo. Advantages are 
offered by iPSC-ECs, as cells can be derived from specific 
individuals for precision medicine and regenerative medi-
cine, and importantly, the type of cells derived could be 
broader. Consistently, a wider range of feature variance was 
observed in this study for iPSC-ECFCs with respect to 
HUVECs, including the response to VEGF. Overall, these 
results demonstrate that iPSC-ECFCs and HUVECs model 
distinct EC types and suggest that iPSC-ECFCs have a 
more heterogeneous/plastic phenotype.
Our measurements showed a clear difference in Jn in 
cells with obviously discontinuous junctions but failed to 
resolve finer differences between untreated and VEGF-
treated HUVECs (Figs. 1B and 2D). We conclude that Jn is 
currently a good proxy to discriminate cells with continu-
ous or discontinuous junctions but not finely tuned to detect 
subtler differences in HUVECs in the absence or presence 
of VEGF (see arrow in Fig. 2B). Further improvement and 
complementary measures, including machine learning-
based classification, could be deployed to classify cells pre-
senting linear versus interdigitated junctions.
NOTCH activation analysis revealed a difference in the 
distribution of cells into the three categories. The iPSC-
ECFCs had a significant fraction (with variance) in the N–/– 
category, while HUVECs were more abundant in the 
N+/– category and when untreated presented a consistent 
fraction of N+/+. This strongly suggests that iPSC-ECFCs 
present an intrinsically lower degree of basal activated 
NOTCH signaling, where this may be already maximally 
activated in HUVECs. NOTCH activation or other signal-
ing readouts could in the future be predicted by morpho-
logical features that show a neighboring loading into 
multidimensional reduction components (Fig. 3A; see also 
Christiansen et al.29). Finally, NOTCH signaling, like many 
other signaling pathways, is extremely dynamic, and inclu-
sion of time-lapse imaging could significantly enrich the 
content, providing new avenues to resolve differences and 
characterize cell model systems.
The framework provided could in fact be extended to 
dynamic imaging data and other diverse biological datasets. 
For example, molecular characterization techniques such as 
Western blotting, quantitative real-time PCR, and RNA 
sequencing, which provide information at the population 
level, may be integrated downstream if required. In the near 
future, these approaches will be attempted more and more 
across different experiments and across different laborato-
ries to allow the analysis of variation to overall increase 
experimental data reproducibility. Multivariate analysis 
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allows the stratification of cell populations and conditions 
throughout multiple experiments. Importantly, predictions 
of correlations between different parameters emerge, allow-
ing serial analyses (e.g., different multicolor panels as with 
cytofluorimetric analysis) on the same cell populations or in 
titration experiments. This could significantly improve the 
development of robust protocols for iPSC differentiation. 
Moreover, such strategies can easily be extended to other 
relevant markers from the same experimental conditions (in 
multiwell plates) and data can be integrated in a single 
database.
Important changes are taking place in cell-based assays 
that extend from the current limitations of traditional cell 
cultures to explore more complex environments.30 Novel 
cell models have been proposed, with particular emphasis 
on 3D culture systems and dynamic analysis of live image 
data. These systems render assay development, data collec-
tion, and analysis workflows more complex. Irrespective of 
the problems of mere computational power, a major bottle-
neck for full fruition is integration of the data. Quantitative 
comparison of different cell models can then be applied to 
diverse cell systems. For selected cell types such as ECs, it 
is tempting to speculate that it would be more fruitful to 
build agile data-integrated analysis platforms first in 2D, as 
these cells form subtle endothelia in vivo, which may well 
be mirrored in these conditions. Solutions, including some 
highlighted here, may next be adapted to complex 3D 
cultures.
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